Rapamune Oral solution 1mg/ml 60ml (Sirolimus Bottles) 1mg/ml 60ml

Rapamune oral solution 1mg/ml 60ml contains sirolimus, an immunosuppressant used to prevent organ transplant rejection. This 60ml bottle is stored between 2-8°C and is suitable for patients requiring long-term immune support. Primary keyword: sirolimus oral solution.

Strength

1mg/ml 60ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

PFIZER LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sirolimus oral solution is primarily used to prevent organ transplant rejection in kidney transplant patients. It may also be prescribed off-label for other conditions requiring immune system modulation. Patients often ask, 'what is sirolimus used for' in transplant care. This medication helps maintain graft function by reducing immune response.

Side Effects

Sirolimus oral solution works by inhibiting specific immune pathways to reduce organ rejection risk. Users may notice improved transplant function over time. Common effects include reduced immune activity, which helps protect transplanted organs. Individual responses vary based on medical condition and treatment plan.

Precautions & Warnings

Store Rapamune oral solution between 2-8°C and protect from light. Use within 30 days of opening. Avoid exposure to extreme temperatures. Keep out of reach of children and pets. Consult a healthcare provider before use if pregnant, breastfeeding, or planning surgery.

Avoid Interactions

Sirolimus may interact with grapefruit, certain antibiotics, antifungals, and other immunosuppressants. Avoid alcohol and consult a doctor before combining with other medications. CYP3A4 inhibitors or inducers can significantly alter sirolimus levels. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Sirolimus oral solution is used to prevent organ transplant rejection, primarily in kidney transplant patients.

Store between 2-8°C and use within 30 days of opening. Protect from light and keep away from children.

Consult your doctor before combining sirolimus with other drugs, as interactions may occur with certain antibiotics or antifungals.

Sirolimus may harm unborn babies. Discuss risks and benefits with your healthcare provider before use.

Common effects include reduced immune activity and potential changes in blood cell counts. Individual responses vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.